Foreign direct investment in India's pharmaceutical industry hit $1.07 billion from April to August, nearly double 2012 figures, triggering government calls to impose new restrictions such as mandatory R&D investment. There is also widespread concern that foreign acquisitions will affect the availability and affordability of generic drugs. India routinely permits 100% foreign investment in new pharmaceutical projects, but acquisitions of existing companies require approval by the Foreign Investment Promotion Board.

Related Summaries